These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 14502230

  • 1. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects.
    Ugai S, Shimozato O, Yu L, Wang YQ, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2003 Oct; 10(10):771-8. PubMed ID: 14502230
    [Abstract] [Full Text] [Related]

  • 2. Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice.
    Shan B, Yu L, Shimozato O, Li Q, Tagawa M.
    Anticancer Res; 2004 Oct; 24(1):79-82. PubMed ID: 15015579
    [Abstract] [Full Text] [Related]

  • 3. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
    Yoshida Y, Tasaki K, Miyauchi M, Narita M, Takenaga K, Yamamoto H, Yaaguchi T, Saisho H, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
    [Abstract] [Full Text] [Related]

  • 4. Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts.
    Ugai S, Shimozato O, Kawamura K, Wang YQ, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2003 Mar; 10(3):187-92. PubMed ID: 12637939
    [Abstract] [Full Text] [Related]

  • 5. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y, O-Wang J, Yu L, Shimozato O, Wang YQ, Takiguchi Y, Tatsumi K, Kuriyama T, Takenaga K, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [Abstract] [Full Text] [Related]

  • 6. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells.
    Yoshida Y, Tasaki K, Kimurai M, Takenaga K, Yamamoto H, Yamaguchi T, Saisho H, Sakiyama S, Tagawa M.
    Anticancer Res; 1998 Jun; 18(1A):333-5. PubMed ID: 9568099
    [Abstract] [Full Text] [Related]

  • 7. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, Tagawa M.
    Int J Cancer; 2005 Jun 20; 115(3):437-42. PubMed ID: 15688376
    [Abstract] [Full Text] [Related]

  • 8. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
    Redlinger RE, Shimizu T, Remy T, Alber S, Watkins SC, Barksdale EM.
    J Pediatr Surg; 2003 Feb 20; 38(2):199-204. PubMed ID: 12596103
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.
    J Gene Med; 2006 Jan 20; 8(1):90-9. PubMed ID: 16097036
    [Abstract] [Full Text] [Related]

  • 10. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells.
    Chiyo M, Shimozato O, Iizasa T, Fujisawa T, Tagawa M.
    Anticancer Res; 2004 Jan 20; 24(6):3763-7. PubMed ID: 15736409
    [Abstract] [Full Text] [Related]

  • 11. Impaired in vivo tumor growth of human pancreatic carcinoma cells retrovirally transduced with GM-CSF gene.
    Kimura M, Tagawa M, Yoshida Y, Takenouchi T, Takenaga K, Azuma K, Yamaguchi T, Saisho H, Sakiyama S.
    Anticancer Res; 1998 Jan 20; 18(1A):165-70. PubMed ID: 9568072
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.
    Oniki S, Nagai H, Horikawa T, Furukawa J, Belladonna ML, Yoshimoto T, Hara I, Nishigori C.
    Cancer Res; 2006 Jun 15; 66(12):6395-404. PubMed ID: 16778218
    [Abstract] [Full Text] [Related]

  • 13. Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma.
    Hu P, Hu HD, Chen M, Peng ML, Tang L, Tang KF, Matsui M, Belladonna ML, Yoshimoto T, Zhang DZ, Xiang R, Ren H.
    Mol Immunol; 2009 May 15; 46(8-9):1654-62. PubMed ID: 19299021
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells.
    Shan BE, Hao JS, Li QX, Tagawa M.
    Cell Mol Immunol; 2006 Feb 15; 3(1):47-52. PubMed ID: 16549049
    [Abstract] [Full Text] [Related]

  • 15. Expression of CD40 ligand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses.
    Wada A, Tada Y, Shimozato O, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M.
    Anticancer Res; 2004 Feb 15; 24(5A):2713-6. PubMed ID: 15517876
    [Abstract] [Full Text] [Related]

  • 16. Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells.
    Wang YQ, Ugai S, Shimozato O, Yu L, Kawamura K, Yamamoto H, Yamaguchi T, Saisho H, Tagawa M.
    Int J Cancer; 2003 Jul 20; 105(6):820-4. PubMed ID: 12767068
    [Abstract] [Full Text] [Related]

  • 17. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY, Chuang TF, Liao KW, Huang YJ, Pai CC, Chu RM.
    Cancer Lett; 2008 Dec 18; 272(2):285-95. PubMed ID: 18760876
    [Abstract] [Full Text] [Related]

  • 18. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
    Suzuki K, Nakazato H, Matsui H, Hasumi M, Shibata Y, Ito K, Fukabori Y, Kurokawa K, Yamanaka H.
    J Leukoc Biol; 2001 Apr 18; 69(4):531-7. PubMed ID: 11310838
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K, Whiteside TL.
    Cancer Gene Ther; 1997 Apr 18; 4(6):366-76. PubMed ID: 9408607
    [Abstract] [Full Text] [Related]

  • 20. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
    Hwang KS, Cho WK, Yoo J, Seong YR, Kim BK, Kim S, Im DS.
    Cancer Gene Ther; 2004 Jun 18; 11(6):397-407. PubMed ID: 15044962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.